Mir Hashim

Mir Hashim

Chief Scientific OfficeratRani Therapeutics Holdings· In proxies 2022–2024

Pay in FY2024-40% from the year before · Rani Therapeutics Holdings stock -58.7% the same year

Mir Hashim was paid $1.3M in FY2024 (Dec), down 40%. Rani Therapeutics Holdings stock fell 58.7% that year.

Pay$100 in the stock at the end of FY21 → $8
Pay is from the Summary Compensation Table of each Rani Therapeutics Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rani Therapeutics HoldingsPublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?